Madewell Bruce R, Gieger Tracy L, Pesavento Patricia A, Kent Michael S
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California 95616, USA.
J Am Anim Hosp Assoc. 2004 Jan-Feb;40(1):47-50. doi: 10.5326/0400047.
Six cats developed malignant lymphoma 3 to 45 months after treatment for vaccine site-associated sarcoma. During the same time period, 184 cats were evaluated in the teaching hospital for vaccine site-associated sarcomas. Feline vaccine site-associated sarcoma is not believed to be associated with feline leukemia virus (FeLV) infection. Five of six cats were negative by enzyme-linked immunosorbent assay for FeLV antigens at the times of diagnosis of both sarcoma and lymphoma, and no cats were infected with feline immunodeficiency virus.
6只猫在接受疫苗接种部位相关肉瘤治疗后3至45个月发生了恶性淋巴瘤。在同一时期,教学医院对184只猫进行了疫苗接种部位相关肉瘤的评估。猫疫苗接种部位相关肉瘤被认为与猫白血病病毒(FeLV)感染无关。6只猫中有5只在肉瘤和淋巴瘤诊断时通过酶联免疫吸附测定法检测FeLV抗原呈阴性,且没有猫感染猫免疫缺陷病毒。